6/16/2009

The FDA said children with attention-deficit/hyperactivity disorder should continue taking medications for their condition because there is no sufficient evidence that the drugs cause sudden death. The warning follows a study partly funded by the agency that cites 10 cases of sudden death in the patient group taking stimulants.

Related Summaries